 |
| Global Artificial Insemination Market Size |
Artificial
insemination is a medically assisted fertilization process, which involves
introducing the semen sample into the female's reproductive tract for
conception. It helps single mothers, same-sex couples, or infertile
heterosexual couples to have children without sexual intercourse. The procedure
avoids the risks and costs associated with multiple implantations or complex
fertility treatments. It has emerged as a preferred alternative to natural
conception or other assisted reproductive technologies like IVF that often
require surgery.
The global
Artificial Insemination Market is estimated to be valued at US$ 9.2 Bn in 2023 and is expected to exhibit a CAGR of 8.1% over the forecast period
2023 to 2030, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
The growing preference for procedures without surgery is one of the key trends
driving the growth of artificial insemination market. Artificial insemination
does not require surgery and complex implantation procedures like IVF
treatments. It is a simpler and more natural procedure compared to IVF and
other advanced fertility treatments. This advantages have increased its
acceptance among consumers. Furthermore, the non-invasive nature and avoidance
of surgery related risks have accelerated the demand for artificial
insemination globally.
Segment
Analysis
The global artificial insemination market is segmented by technology into
intrauterine insemination, intracervical insemination, and intratubal
insemination. The intrauterine insemination segment dominates the market and
accounts for around 60% share globally due to its higher success rate compared
to other technologies. Intrauterine insemination allows placement of sperm
directly into the uterus which provides easier access to the fallopian tubes
and higher chances of conception.
Key Takeaways
Global
Artificial Insemination Market Size is expected to witness high growth
over the forecast period of 2023 to 2030 supported by an increasing prevalence
of infertility worldwide.
Regional
analysis: North America dominates the global artificial insemination market
currently holding around 35% share due to established healthcare
infrastructure, growing prevalence of infertility, and rising focus on family
planning among individuals in the region. Asia Pacific is expected to witness
fastest growth during the forecast period owing to growing medical tourism,
increasing healthcare spending, and rising fertility clinics in major countries
like India and China.
Key players
operating in the artificial insemination market are Pride Angel, Irvine
Scientific, Hi-Tech Solutions, Rinovum Women’s Health, LLC, TenderNeeds
Fertility, Conceivex, Inc., Labotech GmbH, Hamilton Throne Ltd., Biogenics
Inc., Nikon Instruments Inc., Zander scientific Inc., and Surelife Pte Ltd.
These players are focused on expanding their product portfolios and presence in
developing regions through acquisitions and collaborations with hospitals and
fertility clinics.
Explore More Related Article On This
Topic: https://www.ukwebwire.com/artificial-insemination-market-trends/
Explore More Related Article On This
Topic: https://www.newsintv.com/news/offshore-the-decommissioning-a-best-growing-sector/